Protein based COVID-19 vaccine

Description

In this Product Explainer, Infectious Disease Physician and Clinical Microbiologist A/Prof Paul Griffin explains the recombinant protein nanoparticle COVID-19 vaccine with a proprietary adjuvant, including the mechanism of action, efficacy, and tolerability; and provides an update on boosters, indications, and access
(8 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Christopher Soo

Dr Christopher Soo

ADHD in Children – Practical Advice and Update for GPs

Prof Rod Baber

Prof Rod Baber

Oral vs Transdermal MHT – Which Option for Who?

Prof Jason Ong

Prof Jason Ong

The Mpox Emergency – What You Need to Know

Dr Janet Green

Dr Janet Green

Infant and Specialty Formula – What’s in Them and Why

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Paul Griffin

expert

Prof Paul Griffin

Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland;

Date published: 12 July 2023